Dmitry Balyasny’s Tenet Healthcare THC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$262K Sell
1,400
-1,000
-42% -$184K ﹤0.01% 2747
2026
Q1
$453K Sell
2,400
-4,400
-65% -$927K ﹤0.01% 2406
2025
Q4
$1.35M Buy
6,800
+5,700
+518% +$1.15M ﹤0.01% 2054
2025
Q3
$223K Sell
1,100
-18,900
-95% -$3.35M ﹤0.01% 2693
2025
Q2
$3.52M Buy
+20,000
New +$3.01M 0.01% 1464
2020
Q4
Sell
-50,000
Closed -$1.23M 1694
2020
Q3
$1.23M Buy
+50,000
New +$1.28M 0.01% 954

Other funds holding THC

Dmitry Balyasny's THC Position: Q2 2026 in Review

Dmitry Balyasny increased its Tenet Healthcare (THC) stake by 55% in Q2 2026, buying an estimated $118K and bringing the position to 1,807 shares worth $338K. The position accounts for ﹤0.01% of the portfolio, ranked #2673.

Dmitry Balyasny first reported a position in THC in Q2 2013 and has held it in 39 quarters since. The position peaked at $70.3M in Q3 2025. 673 funds tracked by Wall St. Rank hold THC as of Q2 2026.

  • Dmitry Balyasny held 1,807 shares of Tenet Healthcare worth $338K as of Q2 2026.
  • Dmitry Balyasny bought 644 Tenet Healthcare shares in Q2 2026, an estimated $118K.
  • Tenet Healthcare made up ﹤0.01% of Dmitry Balyasny's portfolio in Q2 2026, its #2673 holding.
  • Dmitry Balyasny first reported a position in Tenet Healthcare in Q2 2013 and has held it in 39 quarters since.
  • Dmitry Balyasny's Tenet Healthcare position peaked at $70.3M in Q3 2025.
  • 673 funds tracked by Wall St. Rank held Tenet Healthcare as of Q2 2026.

Based on Balyasny Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.